-Peter A J Forsyth Researcher Activity Profile

Research Author Detailed Information 

Peter A J Forsyth Publication Rate By Year

Peter A J Forsyth has published 1 paper(s) in 1997, 2 paper(s) in 2006, 3 paper(s) in 2007, 1 paper(s) in 2008, for a total of 7 research publications in total.

Peter A J Pa Forsyth Author Information

LAST NAME: forsyth

FIRST NAME: Peter A J

INITIALS: pa

AFFILIATION:

Papers

Peter A J Forsyth's Publication Record

1. Carrier Cell-based Delivery of an Oncolytic Virus Circumvents Antiviral Immunity. Year Published: 2006
1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa Health Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada.
2. Proteolytic disassembly is a critical determinant for reovirus oncolysis. Year Published: 2007
Department of Medical Sciences, Clark Smith Integrative Brain Tumor Research Center, Southern Alberta Cancer Research Institute, University of Calgary, Alberta, Canada.
3. The p75 neurotrophin receptor is a central regulator of glioma invasion. Year Published: 2007
Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.
4. Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin. Year Published: 2007
Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
5. Lymph node metastases from glioblastoma multiforme. Year Published: 1997
Department of Diagnostic Imaging, Foothills Hospital, Calgary, Alberta, Canada.
6. Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors. Year Published: 2008
Authors' Affiliations: Departments of Oncology, Clinical Neurosciences, and Biochemistry and Molecular Biology, University of Calgary, the Tom Baker Cancer Centre, and the Clark H. Smith Brain Tumour Research Centre, Calgary, Alberta, Canada.
7. Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity. Year Published: 2006
Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa Health Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada.